| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |